Stockreport

NovaBay Pharmaceuticals Reports First Quarter 2024 Financial Results

NovaBay Pharmaceuticals, Inc.  (NBY) 
NASDAQ:AMEX Investor Relations: novabay.com/investors
PDF Net product sales increased 13% over the prior year driven by higher sales of Avenova®-branded products through OTC channels and branded wound care productsSales and mar [Read more]